Phase I/II Trial of Mithramycin in Children and Adults With Refractory Extracranial Solid Tumors (Phase I) or Ewing Sarcoma and EWSFLI1 Fusion Transcript (Phase II)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Plicamycin (Primary)
- Indications Ewing's sarcoma; Solid tumours
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 02 Mar 2018 Biomarkers information updated
- 04 Oct 2012 Planned number of patients changed from 42 to 44.
- 08 Jun 2012 New trial record